Phase I trial of an oncolytic virus [Prorvlysin] for prostate cancer.
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2012
At a glance
- Drugs Oncolytic viruses
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 25 Jan 2012 Status changed from planning to recruiting.
- 25 Jan 2012 Planned number of patients changed to 15.
- 27 Sep 2011 New trial record